Adimolol

Iz Wikipedije, slobodne enciklopedije
Idi na navigaciju Idi na pretragu
Adimolol
Klinički podaci
Identifikatori
CAS broj 78459-19-5
ATC kod nije dodeljen
PubChem[1][2] 71227
ChemSpider[3] 64362
UNII B6CJY5K2ST YesY
Hemijski podaci
Formula C25H29N3O3 
Mol. masa 419,52 g/mol
SMILES eMolekuli & PubHem
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Adimolol (MEN-935) je antihipertenzivni agens koji deluje kao neselektivni antagonist α1-, α2-, i β-adrenergičkog receptora .[4]

Reference[uredi - уреди | uredi izvor]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). "PubChem as a public resource for drug discovery.". Drug Discov Today 15 (23-24): 1052–7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). "Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities". Annual Reports in Computational Chemistry 4: 217–241. doi:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). "Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining". J Cheminform 2 (1): 3. PMID 20331846. doi:10.1186/1758-2946-2-3.  edit
  4. Palluk R, Hoefke W, Gaida W, Mierau J, Bechtel WD (July 1986). "Interactions of MEN 935 (adimolol), a long acting beta- and alpha-adrenolytic antihypertensive agent, with postsynaptic alpha-adrenoceptors in different isolated blood vessels--influence of angiotensin II". Naunyn-Schmiedeberg's Archives of Pharmacology 333 (3): 277–83. PMID 3020439. 

Vidi još[uredi - уреди | uredi izvor]